Global Orthopedic Joint Injection Gel 麻豆原创 Research Report 2025

Publication ID:

PB502256097

Publication Date:

February 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Orthopedic Joint Injection Gel was valued at US$ 1945 million in the year 2024 and is projected to reach a revised size of US$ 2483 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Gel for Orthopedic Joint Injection is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Orthopedic Joint Injection Gel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orthopedic Joint Injection Gel.
The Orthopedic Joint Injection Gel market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Orthopedic Joint Injection Gel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orthopedic Joint Injection Gel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orthopedic Joint Injection Gel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orthopedic Joint Injection Gel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Orthopedic Joint Injection Gel 麻豆原创 Overview
1.1 Product Definition
1.2 Orthopedic Joint Injection Gel by Type
1.2.1 Global Orthopedic Joint Injection Gel 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Orthopedic Joint Injection Gel by Application
1.3.1 Global Orthopedic Joint Injection Gel 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Orthopedic Joint Injection Gel 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Orthopedic Joint Injection Gel Revenue 2020-2031
1.4.2 Global Orthopedic Joint Injection Gel Sales 2020-2031
1.4.3 Global Orthopedic Joint Injection Gel 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Orthopedic Joint Injection Gel 麻豆原创 Competition by Manufacturers
2.1 Global Orthopedic Joint Injection Gel Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Orthopedic Joint Injection Gel Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Orthopedic Joint Injection Gel Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Orthopedic Joint Injection Gel, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orthopedic Joint Injection Gel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orthopedic Joint Injection Gel, Product Type & Application
2.7 Global Key Manufacturers of Orthopedic Joint Injection Gel, Date of Enter into This Industry
2.8 Global Orthopedic Joint Injection Gel 麻豆原创 Competitive Situation and Trends
2.8.1 Global Orthopedic Joint Injection Gel 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Orthopedic Joint Injection Gel Players 麻豆原创 Share by Revenue
2.8.3 Global Orthopedic Joint Injection Gel 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Orthopedic Joint Injection Gel 麻豆原创 Scenario by Region
3.1 Global Orthopedic Joint Injection Gel 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Orthopedic Joint Injection Gel Sales by Region: 2020-2031
3.2.1 Global Orthopedic Joint Injection Gel Sales by Region: 2020-2025
3.2.2 Global Orthopedic Joint Injection Gel Sales by Region: 2026-2031
3.3 Global Orthopedic Joint Injection Gel Revenue by Region: 2020-2031
3.3.1 Global Orthopedic Joint Injection Gel Revenue by Region: 2020-2025
3.3.2 Global Orthopedic Joint Injection Gel Revenue by Region: 2026-2031
3.4 North America Orthopedic Joint Injection Gel 麻豆原创 Facts & Figures by Country
3.4.1 North America Orthopedic Joint Injection Gel 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Orthopedic Joint Injection Gel Sales by Country (2020-2031)
3.4.3 North America Orthopedic Joint Injection Gel Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Orthopedic Joint Injection Gel 麻豆原创 Facts & Figures by Country
3.5.1 Europe Orthopedic Joint Injection Gel 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Orthopedic Joint Injection Gel Sales by Country (2020-2031)
3.5.3 Europe Orthopedic Joint Injection Gel Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orthopedic Joint Injection Gel 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Orthopedic Joint Injection Gel 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Orthopedic Joint Injection Gel Sales by Region (2020-2031)
3.6.3 Asia Pacific Orthopedic Joint Injection Gel Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Orthopedic Joint Injection Gel 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Orthopedic Joint Injection Gel 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Orthopedic Joint Injection Gel Sales by Country (2020-2031)
3.7.3 Latin America Orthopedic Joint Injection Gel Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orthopedic Joint Injection Gel 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Orthopedic Joint Injection Gel 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Orthopedic Joint Injection Gel Sales by Country (2020-2031)
3.8.3 Middle East and Africa Orthopedic Joint Injection Gel Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orthopedic Joint Injection Gel Sales by Type (2020-2031)
4.1.1 Global Orthopedic Joint Injection Gel Sales by Type (2020-2025)
4.1.2 Global Orthopedic Joint Injection Gel Sales by Type (2026-2031)
4.1.3 Global Orthopedic Joint Injection Gel Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Orthopedic Joint Injection Gel Revenue by Type (2020-2031)
4.2.1 Global Orthopedic Joint Injection Gel Revenue by Type (2020-2025)
4.2.2 Global Orthopedic Joint Injection Gel Revenue by Type (2026-2031)
4.2.3 Global Orthopedic Joint Injection Gel Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Orthopedic Joint Injection Gel Price by Type (2020-2031)
5 Segment by Application
5.1 Global Orthopedic Joint Injection Gel Sales by Application (2020-2031)
5.1.1 Global Orthopedic Joint Injection Gel Sales by Application (2020-2025)
5.1.2 Global Orthopedic Joint Injection Gel Sales by Application (2026-2031)
5.1.3 Global Orthopedic Joint Injection Gel Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Orthopedic Joint Injection Gel Revenue by Application (2020-2031)
5.2.1 Global Orthopedic Joint Injection Gel Revenue by Application (2020-2025)
5.2.2 Global Orthopedic Joint Injection Gel Revenue by Application (2026-2031)
5.2.3 Global Orthopedic Joint Injection Gel Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Orthopedic Joint Injection Gel Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Orthopedic Joint Injection Gel Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Anika Therapeutics
6.2.1 Anika Therapeutics Company Information
6.2.2 Anika Therapeutics Description and Business Overview
6.2.3 Anika Therapeutics Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Anika Therapeutics Orthopedic Joint Injection Gel Product Portfolio
6.2.5 Anika Therapeutics Recent Developments/Updates
6.3 Seikagaku
6.3.1 Seikagaku Company Information
6.3.2 Seikagaku Description and Business Overview
6.3.3 Seikagaku Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Seikagaku Orthopedic Joint Injection Gel Product Portfolio
6.3.5 Seikagaku Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Company Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zimmer Biomet Orthopedic Joint Injection Gel Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Bioventus
6.5.1 Bioventus Company Information
6.5.2 Bioventus Description and Business Overview
6.5.3 Bioventus Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bioventus Orthopedic Joint Injection Gel Product Portfolio
6.5.5 Bioventus Recent Developments/Updates
6.6 Ferring
6.6.1 Ferring Company Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ferring Orthopedic Joint Injection Gel Product Portfolio
6.6.5 Ferring Recent Developments/Updates
6.7 LG Chem
6.7.1 LG Chem Company Information
6.7.2 LG Chem Description and Business Overview
6.7.3 LG Chem Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.7.4 LG Chem Orthopedic Joint Injection Gel Product Portfolio
6.7.5 LG Chem Recent Developments/Updates
6.8 Freda
6.8.1 Freda Company Information
6.8.2 Freda Description and Business Overview
6.8.3 Freda Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Freda Orthopedic Joint Injection Gel Product Portfolio
6.8.5 Freda Recent Developments/Updates
6.9 Haohai Biological
6.9.1 Haohai Biological Company Information
6.9.2 Haohai Biological Description and Business Overview
6.9.3 Haohai Biological Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Haohai Biological Orthopedic Joint Injection Gel Product Portfolio
6.9.5 Haohai Biological Recent Developments/Updates
6.10 Shanghai Jingfeng
6.10.1 Shanghai Jingfeng Company Information
6.10.2 Shanghai Jingfeng Description and Business Overview
6.10.3 Shanghai Jingfeng Orthopedic Joint Injection Gel Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai Jingfeng Orthopedic Joint Injection Gel Product Portfolio
6.10.5 Shanghai Jingfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orthopedic Joint Injection Gel Industry Chain Analysis
7.2 Orthopedic Joint Injection Gel Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orthopedic Joint Injection Gel Production Mode & Process Analysis
7.4 Orthopedic Joint Injection Gel Sales and 麻豆原创ing
7.4.1 Orthopedic Joint Injection Gel Sales Channels
7.4.2 Orthopedic Joint Injection Gel Distributors
7.5 Orthopedic Joint Injection Gel Customer Analysis
8 Orthopedic Joint Injection Gel 麻豆原创 Dynamics
8.1 Orthopedic Joint Injection Gel Industry Trends
8.2 Orthopedic Joint Injection Gel 麻豆原创 Drivers
8.3 Orthopedic Joint Injection Gel 麻豆原创 Challenges
8.4 Orthopedic Joint Injection Gel 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.